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SUMMARY 
Background: Lipid disorders are common worldwide 
and contribute to a significant proportion of the burden 
of atherosclerotic cardiovascular diseases. 
Objectives: To determine the prevalence of lipid 
disorders among patients reporting at Komfo Anokye 
Teaching Hospital (KATH), Kumasi, Ghana. 
Design: Cross-sectional study. 
Setting: Directorate of Medicine and Polyclinic 
outpatient clinics of KATH. 
Participants: A total of 424 patients, 20 years and 
over reporting for the first time to KATH were 
recruited. 77 had neither diabetes mellitus (DM) nor 
systemic hypertension (HPT) (controls), 94 had only 
DM, 109 had only HPT and 144 had both. 
Methods: A questionnaire was administered after 
informed consent. Anthropometric measurements were 
then taken and blood investigations including total 
cholesterol (TC), high-density lipoprotein cholesterol 
(HDL) and triglycerides (TG) were done. Low-density 
lipoprotein cholesterol (LDL) was calculated using the 
Friedwald formula. The atherogenic index or ratio was 
the ratio of TC to HDL. 
Results: The prevalence of lipid abnormalities was 
60% for high TC, 32% for high TG, 17% for low HDL 
and 61% for high LDL. The mean (± standard 
deviation) TC was 5.33 (± 1.31) mmol/L, mean TG 
was1.52 (± 0.81) mmol/L, mean HDL was 1.65 (± 
0.57) mmol/L and mean LDL was 3.42 (± 1.22) 
mmol/L. The mean atherogenic index was 3.40 and 9% 
of the participants had an atherogenic index more than 
or equal to 5. 
Conclusion: The prevalence of lipid disorders was 
high in adult patients in Kumasi and there is the need to 
increase awareness, screening, detection, treatment and 
control of these disorders. 
 
Key Words: Lipids, Lipid Disorders, Systemic 
Hypertension, Diabetes Mellitus. 
 
INTRODUCTION 
All over the world abnormalities of lipid metabolism 
are common. High serum cholesterol accounts for a 
third of all cardiovascular diseases (CVD) in the world 
and about 105 million people are estimated to have 
cholesterol levels that constitute a cardiovascular risk 
in the USA alone1. Since the Framingham study, which 
clearly showed lipid disorders as a major 
cardiovascular risk factor2, the prevalence of 
abnormalities of lipids has shown a steady rise in all 
countries of the world over the years.1 In the more 
developed countries however with lifestyle 
modifications and the introduction of lipid lowering 
drugs in the recent times, there has been a gradual but 
steady decline in the levels of serum cholesterol and 
this has resulted in the reduction of the incidence rate 
of acute coronary syndrome.3-5 
 
Disorders of blood lipid levels promote atherosclerosis 
which is recognized as a major risk factor for CVD 
such as stroke, coronary artery disease and peripheral 
vascular disease.1 These lipid abnormalities are more 
common in people with diabetes mellitus (DM) and 
systemic hypertension (HPT) and the process of 
atherosclerosis is more aggressive and rapid putting 
these individuals at a greater risk for CVD.6 The three 
conditions, dyslipidaemia, DM and HPT tend to cluster 
in certain individuals, especially in obese subjects.7 
Several lipid studies have been carried out in different 
countries over the years. Dawber et al published one of 
the earliest from the Framingham Study, demonstrating 
clearly that in persons with elevated serum cholesterol 
there is an increased risk for atherosclerotic heart 
disease.2 The serum lipid levels in healthy Nigerians 
was found to be generally lower than in Caucasians by 
Adedeji8 and similar findings were obtained in early 
studies in Accra, Ghana.9-16 
 
In Kumasi, Ghana two main lipid studies have been 
carried out. One was a hospital-based study at Komfo 
Anokye Teaching Hospital (KATH), Kumasi which 
was carried out in 1999-2000 and published in 2003. 
The second was a community based study undertaken 
in 2001-2002 in communities surrounding Kumasi.17,18 
The mean serum total cholesterol (TC) and the 
prevalence of hyperlipidaemia from these studies were 
remarkably different. Further it is over five years since 
these studies were undertaken and it is possible that the 
pattern of lipid disorders may have changed.  
 
 
March 2012    F. B. Micah and B. C. Nkum                  Lipid studies in Kumasi 
 15 
Further lipid studies, the authors believe will be of 
relevance to both the clinician in the hospital as well as 
the policy makers. Such studies will increase 
awareness and promote screening for lipid 
abnormalities in patients at the hospital and will also 
increase advocacy among policy makers for more 
facilities for prevention, early detection and treatment 
of lipid abnormalities. The authors therefore find it 
very important for further lipid studies to determine the 
prevalence of lipid disorders and determine the current 
levels of lipids in Kumasi. Our main objective for this 
study was to determine the prevalence of lipid 
disorders among patients reporting at KATH, Kumasi, 
Ghana. 
 
MATERIALS AND METHODS 
The study was a cross-sectional study conducted at 
KATH, a referral and tertiary teaching hospital with 
1000 beds located in Kumasi, the second most 
populated city in Ghana. The study participants were 
recruited from the Polyclinic Directorate and the 
Directorate of Medicine from April 2008 to January 
2009.The inclusion criteria were as follows: All new 
patients reporting at the outpatient clinic during the 
study period; patients who were 20 years and over; 
patients who consented to the study by completing the 
informed consent form and patients who were treated 
on outpatient basis.  
 
The exclusion criteria were as follows: Patients who 
refused to consent; patients who were known or found 
to have liver cirrhosis during the interview and/or 
examination; patients who were unable to stand for 
their height and weight to be measured; and patients 
who were detained or admitted to the ward. 
 
A questionnaire was administered and a physical 
examination carried out on each participant by one of 
the authors. Blood pressure (BP) and pulse rate were 
measured with an automatic BP machine (OMRON M7 
sphygmomanometer; Omron Matsusaka Co. Ltd, 
Matsusaka City, Mie-Ken, Japan) using the appropriate 
size of cuff, after participants had been sitting 
undisturbed for at least five minutes. Three readings 
were taken one minute apart. The first reading was 
used to familiarize the patient to the procedure and was 
discarded and the mean of the last two readings was 
used in the data analysis. Height was measured to the 
nearest 0.5 cm and weight was measured to the nearest 
0.1 kg after participants had removed their footwear 
using a standardized combined manual scale and 
stadiometer (Asimed MB 201T Plus from Aparatos Y 
Sistemas De Medida, S. A.).  
 
Hip and waist circumferences were measured to the 
nearest 0.5 cm using a plastic tape measurement. The 
participants were then given the appropriate medical 
treatment and were requested to come back the 
following morning after an overnight fast for serum 
biochemical investigations which included fasting 
blood glucose (FBG), fasting lipid profile, liver 
function test, urea, creatinine and electrolytes as well 
as urine examination.  
 
Ten ml of venous blood was drawn from the 
antecubital vein of each participant and this was 
separated into fluoride and EDTA tubes. The blood 
was allowed to stand for at least 30 minutes after which 
serum was separated by centrifugation at 3000 rpm for 
10 minutes. The separated serum and the sample from 
the fluoride tubes were analysed using a BT3000 auto 
analyser, manufactured by Biotechnica Instruments 
S.p.A. Rome, Italy. Total cholesterol (TC), high 
density lipoprotein cholesterol (HDL), triglycerides 
(TG), urea, creatinine, albumin, total protein, bilirubin, 
aspartate transaminase (AST), alanine transaminase 
(ALT), alkaline phosphatase (ALP) and gamma-
glutamyl transferase (GGT) were all determined by 
colorimetric methods. The level of low-density 
lipoprotein cholesterol (LDL) was calculated using the 
Friedwald formula.19 
 
The following definitions were adopted for this study: 
1. Systemic hypertension is systolic blood pressure 
(SBP) ≥ 140 and / or diastolic blood pressure (DBP) ≥ 
90.20 
2. Overall Obesity is Body Mass Index (BMI) ≥ 30 
kg/m.2,21  
3. Central Obesity or High Waist Hip Ratio (WHR) is 
WHR > 0.9 for males and > 0.8 for females.22 
4. Diabetes mellitus.22 Fasting venous blood glucose ≥ 
6.1 mmol/L and or 2h post prandial capillary whole 
blood ≥ 11.1 mmol/L7 or being on drug or diet therapy 
for DM. 
5. Lipid disorders were defined as follows; high serum 
TC, TC >5.0mmol/l;high serum TG, TG >1.7mmol/l; 
high serum LDL was LDL >3.0mmol/l and low serum 
HDL,HDL <1.0mmol/l in males and HDL <1.2mmol/l 
in females.7 
6. Atherogenic index was defined as the ratio of TC to 
HDL and high atherogenic index was defined as a ratio 
greater or equal to 5.23 
7. Controls were participants who were not classified 
as having HPT or DM or both by the above definitions. 
All participants gave formal consent by signing or 
thumb printing an informed consent form after the 
study has been thoroughly explained to them. 
 
The study was approved by the Committee of Human 
Research, Publication and Ethics of KATH and School 
of Medical Sciences, Kwame Nkrumah University of 
Science and Technology. 
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The formula from “A Practical Manual” was used to 
calculate the study population sample size.24 With an 
estimated prevalence of lipid disorders of 50%, a 
confidence level of 95% and a margin of allowable 
error of 5% the estimated sample size was 384.  
 
DATA ANALYSIS/CALCULATIONS 
Information from all the subjects was recorded on a 
questionnaire and data entry form. These were 
subsequently entered on a computer using Epidata 3.1 
software by double entry. The percentage or 
proportions were calculated for discrete variables while 
the mean with its standard deviation were computed for 
continuous variables. The Student t-test was used to 
compare continuous variables and the Pearson Chi-
square test for discrete variables.  The data was 
categorized into two main categories, a clinical group 
and an age group. The clinical group was made of 
controls, DM only, HPT only and both DM and HPT, 
while the age group was made up of <40, 40-<50, 50- 
<60 and ≥60 years. Where a continuous variable has 
been divided into levels one-way analysis of variance 
was used to compare the respective continuous 
variables. Also in these same situations a formal test 
for trend of increasing categorical variables was done 
using nptrend test from Stata. Univariate and 
multivariate regression analysis was also carried out 
with TC, TG, HDL and LDL as the independent 
outcome variables. The following variables, sex, age, 
height weight, BMI, SBP, DBP and FBG were used as 
the dependent variables. p-values of less than 0.05 
were taken as statistically significant.  
 
RESULTS 
In all 424 subjects participated in this study, 163 (38%) 
males and 261 (62%) females giving a male:female 
ratio of 1:1.6. Majority of the participants were of the 
Ashanti ethnic group, 306 (72%), 20 (5%) were Fantis 
while the remaining 98 (23%) were made of other 
Ghanaian ethnic groups.  
 
Eighty-six (20%) of participants never had formal 
education, 78 (18%) had completed primary school, 
130 (31%) middle school, 61 (15%) secondary school, 
47 (11%) technical training and 22 (5%) tertiary or 
university education. Sixty-six (16%) of the 
participants were government employees, 41 (10%) 
were non-government employees, 34(8%) were 
farmers, 141 (33%) were traders, 65 (16%) were 
retired, 17 (4%) were unemployed while the remaining 
60 (14%) were made up of students, housewives and 
self-employed people. Most of the participants were 
married, 279 (66%), 55 (13%) were separated or 
divorced, 53 (13%) were widowed, 34 (8%) were 
single and 3 (less than 1%) were cohabiting. 
 
The mean (standard deviation) age for the participants 
was 50 (14) years with no significant age difference 
between the males and females (Table 1). Weight was 
similar in the sexes but the men were taller so their 
BMI was significantly lower than the women. Both 
SBP and DBP were similar in men and women. The 
prevalence of high BMI (32% vrs 6%, p<0.001) and 
high WHR (88% vrs 50%, p<0.001) was higher in the 
women than the men. Seventy-seven (18%) of the 
participants had neither HPT nor DM (control group), 
94 (22%) had only DM, 109 (26%) had only HPT and 
144 (34%) had both DM and HPT. 
 
Table 1 Characteristics of participants by sex 
Variable Male Female Total p-value 
N (%) 163 (38.4) 261 (61.6) 424  
Age (years) 
Mean (SD) 
48.6 (14.3) 50.6 (13.2) 49.8 (13.7) 0.15 
Age range 
(years) 
21 - 88 20 - 83 20 - 88  
Weight(kg)
Mean (SD) 
68.9 (12.0) 68.3 (14.5) 68.5 (13.6) 0.65 
Height (m) 
Mean (SD) 












 84 (12) 84 (12) 0.95 
 
There was no significant sex, weight and height 
difference between the four clinical groups. Mean BMI 
as well as percentage of high BMI (BMI ≥ 30) were 
also not different in the four clinical groups. However 
there were significant difference in age (p<0.0001), 
SBP (p<0.0001), DBP (p<0.0001) and prevalence of 
high WHR (p<0.001). These latter parameters 
increased as one moved from the control group through 
the DM only and HPT only groups to the DM - HPT 
group. There was also a statistically significant 
difference for increasing trend from the control group 
to the DM - HPT group (p <0.01) for these parameters.  
 
In this study 253 (59.7%) were classified as having 
HPT from the definition of HPT adopted for the study. 
However, 198 participants were detected or known 
HPT patients while the remaining 55 were undetected, 
giving a detection rate (proportion of participants who 
knew they had the disease compared to the total 
number of participants who had the disease after the 
survey) of 78.3%. On the other hand 198 of the study 
participants who were known DM patients on diet or 
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some pharmacological treatment for DM and a further 
40 were classified as DM giving a total of 238 (56.0%) 
and a detection rate of 83.2%. Only 16 (3.9%) of the 
participants were aware that they had dyslipidaemia or 
hyperlipidaemia. Of this number, 6 had only high TC, 
8 had only high TG, 2 had only high LDL and 2 had 
both high LDL and high TG. None of the 16 had low 
HDL. In all 259 (61.1) participants had high LDL and 
253 (59.7) had high TC. Though these figures cannot 
be compared directly with the 16 who knew they had 
lipid disorders it gives an idea of how low the detection 
rate for lipid disorders in this population of patients 
would be. 
 
Table 2 Mean fasting blood glucose and serum lipids 
by sex 







































3.55 (1.12) 3.42 (1.22) 0.04 
 
The mean FBG was 8.08 (± 4.46) mmol/L and there 
were no significant sex difference. The mean serum TC 
was 5.33 (± 1.31) mmol/L, mean TG was1.52 (± 0.81) 
mmol/L, mean HDL was 1.65 (± 0.57) mmol/L and 
mean LDL was 3.42 (± 1.22) mmol/L (Table 2) Mean 
TG and HDL were similar in males and females but 
both the mean TC and LDL were significantly higher 
in the females. 
 
There was no significant difference in the mean FBG in 
the various age groups. Mean HDL was higher in the 
≥60 age group than the other age groups (<40, 40-<50 
and 50- <60 years) though this was not statistically 
significant. There were significant differences in the 
various age groups in mean TC (p<0.001), mean TG 
(p<0.0001) and mean LDL (p<0.01). Mean TC, TG 
and LDL increased from the younger age groups to the 
older groups and the statistical test for increasing trend 
was positive (p<0.01). The mean FBG was 
significantly higher in normotensive DM patients and 
DM- HPT patients than in the control and HPT groups 
(p<0.0001). There were significant clinical group 
differences for mean TC (p<0.0001), TG (p<0.0001) 
and LDL (p=0.02) but HDL was similar in the various 
clinical groups. There was a statistically significant test 
for increasing trend for mean TC, TG and LDL as one 
moved from the control group to the DM - HPT group 
(p <0.01). 
 
When the participants were stratified by sex and 
clinical group there were significant sex difference in 
the control group in the mean TC (p<0.05), LDL 
(p<0.05) and HDL (p<0.01). There was no difference 
between the two sexes in the DM group. The mean 
LDL level was significantly raised in the females in the 
HPT (p<0.01) group while the females in the DM - 
HPT group had a significantly elevated mean TG 
compared to the males (p<0.05). 
 
Table 3 Prevalence of lipid disorders by sex 
Veriable Male Female Total p-value 
 n (%) n (%) n (%) χ2 test 
N (%) 163 (38.4) 261 (61.6) 424  
TC > 5.0 
(mmol/L) 
83 (50.9) 170 (65.1) 253 
(59.7) 
<0.01 
TG > 1.7 
(mmol/L) 
43 (26.4) 93 (35.6) 136 
(32.1) 
0.05 
HDL < 1.0 (M)  
HDL < 1.2 (F) 
(mmol/L) 
15 (9.2) 55 (21.1) 70 (16.5) <0.01 
LDL > 3.0 
(mmol/L) 
89 (54.6) 170 (65.1) 259(61.1) 0.03 
 
The mean atherogenic index was 3.40 (± 1.16). The 
males had an atherogenic index of 3.32 (± 1.14) and 
this was not significantly different from that of the 
females 3.46 (± 1.18) (p=0.34). The atherogenic index 
of the control group was 3.16 (± 1.34), the DM patients 
3.31 (± 1.04), the HPT patients 3.32 (± 1.13) and the 
patients with both DM and HPT 3.61 (± 1.16). There 
were no significant differences between these 
atherogenic indices (p=0.13). There were no significant 
differences in the atherogenic indices of the various 
age groups (p=0.11).  
 
The majority of the participants (91%) had an 
atherogenic index below 5 with only 9% having a high 
atherogenic index. There were no significant sex 
difference in the prevalence of high atherogenic index 
(p=0.56), no significant clinical group difference 
(p=0.90) and neither age group difference (p=0.98).  
 
The prevalence of lipid disorders was 60% for high 
TC, 32% for high TG, 17% for low HDL and 61% for 
high LDL (Table 3). 
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The prevalence was significantly higher in the females 
for high TC, high TG and low HDL but the prevalence 
of high LDL was not statistically significant. 
 
In Table 4 the prevalence of high TC, high TG and 
high LDL increased from the less than 40 age group to 
the ≥60 age group. The prevalence of low HDL showed 
no particular pattern and the differences were not 
significant. 
 
Table 4 Prevalence of lipid disorders by age 
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Table 5 shows the prevalence of lipid disorders by the 
different clinical groups. There were no significant 
differences in the clinical group prevalence of low 
HDL. However the prevalence of high TC, high TG 
and high LDL increased from the control group to the 
DM - HPT group. There was a statistically significant 
test for increasing trend for high TC, high TG and high 
LDL as one moved from the control group to the DM -
HPT group (p <0.01). 
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In multivariate regression analysis TC remained 
associated with SBP (r=0.01, p<0.01) but not DBP and 
FBG after controlling for sex, age and weight. TG was 
still associated with FBG (r=0.02, p<0.01) and SBP 
(r=0.01, p<0.01) but not DBP upon controlling for sex, 
age and weight. Also HDL was still associated with 
FBG (r=-0.01, p=0.05) but not with SBP and DBP after 
controlling for age and sex. There was no association 
between SBP, DBP, FBG and LDL after adjusting for 
various variables. 
 
Table 6 shows the results of the univariate regression 
analysis. TC was associated with the following; sex, 
age, weight, height, BMI, SBP and DBP. There was no 
association with FBG. age, height, BMI, FBG, SBP 
and DBP were associated with TG. LDL was 
associated in univariate analysis with sex, age, weight, 
height, and BMI.  There were no association between 
LDL and SBP, DBP and FBG. HDL was associated 
with FBG but not with SBP and DBP. 
 
Table 6 Correlation (r) of various variables with TC, 
TG, HDL and LDL as the outcome variable (p=p-
value) 
 TC TG HDL LDL 
 r p r p r p r p 
Sex 
(years) 
0.41 <0.01 0.14 0.08 0.04 0.57 0.31 0.04 
Age 
(years) 
0.02 <0.001 0.01 <0.001 0.003 0.30 0.02 <0.01 
Weight 
(kg) 





<0.01 -1.39 <0.01 -0.20 0.67 -2.50 0.01 
BMI 
(kg/m2) 
0.07 <0.001 0.02 <0.01 0.004 0.59 0.07 <0.001 
SBP 
(mmHg) 
0.01 <0.001 0.01 <0.001 0.001 0.48 0.01 0.07 
DBP 
(mmHg) 
0.02 <0.001 0.01 <0.01 0.004 0.22 0.01 0.10 
FBG 
(mmol/L) 
0.01 0.58 0.02 0.01 -0.01 0.05 0.004 0.80 
 
DISCUSSION 
This study has indeed shown that lipid disorders are 
common in Kumasi, Ghana. These patients had high 
levels of all the serum lipids and the prevalence of high 
TC and LDL was particularly high. Generally these 
disorders were identified in all the different groupings 
of patients but they were more common in women, in 
older patients and in patients with both DM and HPT. 
The mean atherogenic index and the prevalence of high 
atherogenic index were both low. The prevalence of 
lipid disorders was 60% for high TC, 32% for high TG, 
17% for low HDL and 61% for high LDL.  
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These prevalence rates were very high by all standards 
especially for high LDL and high TC.  Similar results 
have been obtained in the previous study at KATH 
with high TC of 45%, high TG of 26%, low HDL of 
31% and high LDL was also 72%17. Such high 
prevalence of these lipid disorders definitely increases 
the risk of these patients for atherosclerotic CVD such 
as stroke, coronary artery disease and peripheral 
vascular disease especially in the group with DM, HPT 
and DM - HPT. The prevalence was particularly high 
in women, in older age groups and in the DM - HPT 
groups. The lowest values of prevalence were recorded 
in all the instances in the control group indicating the 
increased burden of risk in participants with DM and 
HPT. The good news was that low HDL prevalence 
was low, 17% in this study and about half compared to 
31% reported in the previous study (Pearson Chi-
square test p<0.0001).17 This low prevalence was in 
both females and males as well as in all the clinical 
groupings that were analysed. This implies that most of 
the participants have levels of HDL which confers 
some protection against CVDs. 
 
The community study from Kumasi had reported 8.7% 
of participants as having TC above 5.20 mmol/L and 
8.2% with serum TG greater than 1.70 mmol/L.18 
These results were remarkably low compared to the 
findings in our study. This is not surprising since this 
was not a hospital-based study. Idogun et al reported a 
prevalence of lipid abnormalities of between 25-69% 
among DM patients with and without complications 
from Benin, Nigeria25. Akpa et al found a prevalence of 
high TC of 31.52% in a community survey in Port 
Harcourt, Nigeria26. This prevalence was also low, as 
one would expect from a community-based study. 
Among 141 healthy male blood donors at Korle-Bu 
Teaching Hospital, Asibey-Berko and Avorkliyah 
found 18% of this study population had a TC above 5.2 
mmol/L.12 This prevalence was much lower than our 
findings but then the Accra participants were healthy 
blood donors who were likely to be much younger and 
healthier than the participants in our study. In the 
Women’s Health Study of Accra, it was shown that 
25% of women in Accra had an elevated TC.15,16 
 
The mean TC, mean TG, mean HDL and mean LDL 
were 5.33 (± 1.31) mmol/L, 1.52 (± 0.81) mmol/L, 1.65 
(± 0.57) mmol/L and 3.42 (± 1.22) mmol/L 
respectively. Mean HDL was not significantly different 
in men and women and there were not significant 
clinical group difference. However upon stratification 
by sex and clinical group the females in the control 
group had significantly higher HDL levels compared to 
the males in the control group. Mean LDL and TC 
were significantly elevated in the women and they also 
increased as you moved from the control group to the 
DM - HPT group. Mean TG showed a similar trend for 
the clinical groups but there were no sex differences.  
 
Mean TC, TG and LDL increased with increasing age 
groups and demonstrating a clear trend. Mean HDL 
was similar in the various age groups and was rather 
high in the ≥60 age group though this was not 
statistically significant. Oyelolola et al reported similar 
findings to this study.27 They found HPT and DM  HPT 
subjects to have higher mean TC, LDL and TG than 
controls. However mean HDL was significantly lower 
in the normotensive subjects with DM. Nyarko et al in 
an earlier study in 1997 found the levels of cholesterol 
to be similar in subjects with DM, HPT and age-
matched healthy controls.11 In a latter study in 2003 
however TC and LDL levels were similar to the earlier 
study but the levels in apparently healthy controls were 
much lower than previously28. Hence there was 
statistically significantly elevation of the TC and LDL 
in the persons with DM and HPT compared to the 
healthy control group.28 
 
The results of Eghan and Acheampong are similar to 
the findings of this study.17 They reported mean TC, 
mean TG, mean HDL and mean LDL of 5.13 (±1.39) 
mmol/L, 1.48 (±0.81) mmol/L, 1.30 (±0.63) mmol/L 
and 3.29 (±1.22) mmol/L respectively.17 The mean TC, 
TG and LDL were not significantly different from the 
results of this study (t-test p>0.05) but the mean HDL 
1.30 (±0.63) mmol/L was significantly lower than the 
reported mean of 1.65 (± 0.57) in this study (t-test 
p<0.0001). Therefore over this period of about 9 to 10 
years since the other study was conducted the serum 
lipid levels of patients have not worsened and but 
rather the antiatherogenic HDL portion has 
significantly increased. This observed increase in HDL 
while the TC and the other components remained 
stable may be due to increase in physical activity as a 
result of health education. In the US over a 10-year 
period of recent measurements in the Framingham 
Study, there was a decrease in dyslipidaemia with a 
decrease in TG levels and an increase in the levels of 
HDL and this was in spite of an overall increase in 
BMI.5 
 
Atherogenic index is the ratio of TC to HDL and is 
used as a predictor of atherosclerosis and 
cardiovascular risk with a higher ratio indicating an 
increased risk and vice-versa.23,29-32 In this study the 
mean atherogenic index was 3.40 and there were no 
significant sex, age or clinical group differences. The 
goal is to keep the atherogenic index below 5 and the 
optimum ratio is 3.5. The mean ratio of 3.32 for males 
and 3.46 for females was therefore in the optimum 
range. Further only 9% of participants had an index 
higher than five, which was very good considering the 
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fact that 60% of these same participants had levels of 
TC which were high. Oyelola et al reported a TC/HDL 
ratio of 4.97 (± 1.44) for persons with DM, 5.38(±3.25) 
for HPT, 5.86(±1.95) for DM - HPT and 3.15 (±1.01) 
for a control group.27 These results were much higher 
compared to the results of this study. 
 
Using simple linear and multiple regression analysis 
this study also explored whether any relationship 
existed between serum lipids, FBG, SBP and DBP in 
this patient population. After controlling for various 
confounding variables in multivariate analysis, TC was 
associated with SBP, TG was associated was 
associated with SBP and FBG and HDL was associated 
with FBG. LDL was not associated with any of the 
variables. These results do not show a definite pattern 
but at least it shows that SBP is an important 
determinant of TC and TG while FBG explained most 
of the effect of TG and HDL. Akuyam et al reported a 
positive and significant association between TC and BP 
in both normotensives and subjects with HPT33. 
Nyarko et al found no association between lipid levels 
and both FBG levels and BP in Accra.11 
 
One important issue that came out strongly in this 
study was the sheer magnitude of ignorance of lipid 
abnormalities among the patients studied. Firstly there 
were no clear or popular terminology in the local 
vernacular for lipid disorders compared to DM and 
HPT. Secondly there is very little public health 
education on lipid disorders especially on radio and 
television programmes. As a result most of the 
participants have never heard of the condition and were 
not aware that it was a disease state that is treatable. 
Only 16 participants had been told that they had a form 
of lipid abnormality and out of this number 6 of them 
were on treatment with statins. Considering the fact 
that this study classified 61% and 60% of participants 
as having high LDL and high TC respectively, this 
paints a picture of a very low rate of detection, 
treatment and control of lipid disorders among this 
patient population. Especially taking into account that 
the detection rate of HPT was 78% and DM had a 
detection rate of 83% among the same group of 
participants. These latter rates were high by most 
standards and commendable. 
 
CONCLUSION 
The prevalence of lipid disorders among adult patients 
in Kumasi was high. The mean serum lipids were also 
high but the detection rate of lipid disorders was low. 
In view of these findings there is the urgent need to 
increase awareness, screening, detection, treatment and 
control of these lipid disorders in patients in Kumasi. 
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